Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection 2023-09-15 20:30
Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000 2023-09-15 16:00
Green Leadership Award Presented to Chugai Pharma Taiwan at the Asia Responsible Enterprise Awards 2023 2023-09-15 11:37
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study 2023-09-15 08:00
Cure Genetics and Frametact Reach a $60 Million Collaboration and Licensing Agreement for the Development of Gene Therapy for Familial Neurological Diseases 2023-09-14 23:00
Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease 2023-09-14 20:00
Porton Advanced and BRL Medicine Build Strategic Partnership to Accelerate Commercialization of Gene and Cell Therapies 2023-09-14 20:00
Foundry Mixer Healthcare, Indonesian Minister of Health Budi G. Sadikin: "Together We Leapfrog Indonesia's Healthcare Transformation" 2023-09-14 17:47
Dizal Announces China CDE Acceptance of New Drug Application for Golidocitinib for Relapsed or Refractory PTCL 2023-09-14 17:07
Asieris' New Drug APL-1401 Completes First Administration in Patient with Moderately to Severely Active UC 2023-09-14 16:54
Nona Biosciences Expands Antibody Discovery Collaboration with BeiGene 2023-09-14 16:00
Innovative Collaboration: Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan 2023-09-14 10:00
Exelixis and Insilico Medicine Enter into Exclusive Global License Agreement for ISM3091, a Potentially Best-in-Class USP1 Inhibitor 2023-09-13 20:29
J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI 2023-09-13 15:58
Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China 2023-09-13 14:24
Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7 2023-09-13 13:42
Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets 2023-09-13 10:30
GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC. 2023-09-13 00:00
Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration 2023-09-12 20:00
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA 2023-09-12 19:24
1 41 42 43 44 45 374